Mouwasat Medical Services Company (TADAWUL:4002)
Saudi Arabia · Delayed Price · Currency is SAR 60.25
+0.25 (0.42%)
Jul 23, 2026, 3:19 PM AST
TADAWUL:4002 Financials Overview
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,292 | 3,223 | 2,879 | 2,706 | 2,334 | 2,144 |
Revenue Growth | 12.71% | 11.92% | 6.43% | 15.91% | 8.86% | 4.85% |
Gross Profit Gross Profit Growth | 1,352 | 1,342 | 1,214 | 1,295 | 1,085 | 981.46 |
Operating Income Operating Income Growth | 872.51 | 878.76 | 723.57 | 756.56 | 672.46 | 621.93 |
Net Income Net Income Growth | 826 | 822.04 | 645.76 | 657.69 | 599.31 | 578.16 |
Earnings Per Share EPS Growth | 4.13 | 4.11 | 3.23 | 3.29 | 3.00 | 2.89 |
EPS Growth | 23.06% | 27.30% | -1.81% | 9.74% | 3.66% | 9.47% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pharmaceuticals Pharmaceuticals Growth | 498.22 | 486.66 | 451.17 | 392.95 | 319.64 | 278 |
Medical Services Medical Services Growth | 2,794 | 2,736 | 2,428 | 2,313 | 2,014 | 1,866 |
Total Total Growth | 3,292 | 3,223 | 2,879 | 2,706 | 2,334 | 2,144 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 490.99 | 497.45 | 511.57 | 149.05 | 254.88 | 256.87 |
Total Debt Total Debt Growth | 1,154 | 989.49 | 761.68 | 788.48 | 892.16 | 828.86 |
Net Cash (Debt) Net Cash Growth | -662.77 | -492.04 | -250.1 | -639.43 | -637.28 | -571.99 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -3.31 | -2.46 | -1.25 | -3.20 | -3.19 | -2.86 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,218 | 1,178 | 1,256 | 813.78 | 707.33 | 682.83 |
Capital Expenditures CapEx Growth | -526.25 | -409.63 | -429.02 | -277.04 | -292.81 | -326.94 |
Free Cash Flow Free Cash Flow Growth | 691.55 | 768.09 | 827.41 | 536.75 | 414.52 | 355.9 |
Free Cash Flow Growth | -22.37% | -7.17% | 54.15% | 29.49% | 16.47% | 41.90% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 41.07% | 41.65% | 42.17% | 47.85% | 46.48% | 45.77% |
Operating Margin | 26.50% | 27.27% | 25.13% | 27.96% | 28.81% | 29.01% |
Pretax Margin | 26.58% | 27.41% | 24.51% | 26.87% | 28.29% | 29.48% |
Profit Margin | 25.09% | 25.51% | 22.43% | 24.31% | 25.68% | 26.96% |
FCF Margin | 21.01% | 23.83% | 28.74% | 19.84% | 17.76% | 16.60% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 2.250 | 2.125 | 2.000 | 1.750 | 1.500 | 1.375 |
Dividend Per Share Growth | 6.25% | 6.25% | 14.29% | 16.67% | 9.09% | 10.00% |
Dividend Yield | 3.73% | 3.24% | 2.49% | 1.68% | 1.56% | 1.74% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.59 | 16.22 | 26.36 | 34.00 | 34.87 | 30.06 |
Forward PE | 13.95 | 16.67 | 20.61 | 30.17 | 29.27 | 26.82 |
P/FCF Ratio | 17.42 | 17.36 | 20.57 | 41.66 | 50.42 | 48.83 |
PS Ratio | 3.66 | 4.14 | 5.91 | 8.27 | 8.95 | 8.11 |